Influence Analysis of Salmeterol Fluticasone and Budesonide to Lung Function of Patients with Bronchial Asthma

Chen Cuiy
Abstract:Objective: To probe into clinical effect of salmeterol fluticasone on patients of bronchial asthma cured and its effect on pulmonary function. Methods: Seventy-eight patients who suffered from the bronchial asthma and received treatment in our hospital from March,2012 to March,2014 were enrolled in this study. They were randomly divided into the group A and group B,with 39 patients in each group. The patients in group A were treated with the salmeterol fluticasone while in the B group treated with the budesonide. Then,the treatment effect,improvement of pulmonary function( FEV1,FVC and PEF) and the occurrence rate of adverse reactions( nasal and gular discomfort,trachyphonia and local excitation) of these two groups of patients were observed. Results: The whole effective rate of treatment in group A was 92. 31%,compared with 79. 49% in group B,and the differences were statistically significant( P 0. 05). Before treatment,there were no differences in FEV1,FVC and PEF between group A and B. However,after treatment,the indexes were improved significantly and the indexes in group A were significantly better than their counterparts in B group( P 0. 05). The occurrence rate of adverse reactions in group A was 5. 13%,compared with 7. 69% in group B,and the differences were not statistically significant( P 0. 05). Conclusion: Salmeterol fluticasone is better than budesonide in treating chronic moderate bronchial asthma and in improving pulmonary function. Besides,salmeterol fluticasone results in less adverse reactions than budesonide. Therefore,salmeterol fluticasone deserves being promoted in the clinical application.
Medicine
What problem does this paper attempt to address?